Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 5;22(6):bbab134.
doi: 10.1093/bib/bbab134.

Knowledge bases and software support for variant interpretation in precision oncology

Affiliations

Knowledge bases and software support for variant interpretation in precision oncology

Florian Borchert et al. Brief Bioinform. .

Erratum in

  • Knowledge bases and software support for variant interpretation in precision oncology.
    Borchert F, Mock A, Tomczak A, Hügel J, Alkarkoukly S, Knurr A, Volckmar AL, Stenzinger A, Schirmacher P, Debus J, Jäger D, Longerich T, Fröhling S, Eils R, Bougatf N, Sax U, Schapranow MP. Borchert F, et al. Brief Bioinform. 2021 Nov 5;22(6):bbab246. doi: 10.1093/bib/bbab246. Brief Bioinform. 2021. PMID: 34125166 Free PMC article. No abstract available.

Abstract

Precision oncology is a rapidly evolving interdisciplinary medical specialty. Comprehensive cancer panels are becoming increasingly available at pathology departments worldwide, creating the urgent need for scalable cancer variant annotation and molecularly informed treatment recommendations. A wealth of mainly academia-driven knowledge bases calls for software tools supporting the multi-step diagnostic process. We derive a comprehensive list of knowledge bases relevant for variant interpretation by a review of existing literature followed by a survey among medical experts from university hospitals in Germany. In addition, we review cancer variant interpretation tools, which integrate multiple knowledge bases. We categorize the knowledge bases along the diagnostic process in precision oncology and analyze programmatic access options as well as the integration of knowledge bases into software tools. The most commonly used knowledge bases provide good programmatic access options and have been integrated into a range of software tools. For the wider set of knowledge bases, access options vary across different parts of the diagnostic process. Programmatic access is limited for information regarding clinical classifications of variants and for therapy recommendations. The main issue for databases used for biological classification of pathogenic variants and pathway context information is the lack of standardized interfaces. There is no single cancer variant interpretation tool that integrates all identified knowledge bases. Specialized tools are available and need to be further developed for different steps in the diagnostic process.

Keywords: HiGHmed; cancer therapy; data integration; molecular tumor board; personalized medicine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of the diagnostic process in precision oncology. Within this process, knowledge bases can be attributed to the three main diagnostic steps biological classification of a variant, clinical classification and knowledge bases supporting therapy recommendations. Semi-automatic or manual literature search supports the entire process. The diagnostic process is performed by an interdisciplinary team of physicians and scientists. The exact composition and responsibilities within the team vary between university centers.
Figure 2
Figure 2
Survey results and tool integration for KBs. We report the overall fraction of survey participants who responded to use the KBs. The individual responses can be found in the supplementary data. We also report the number of citations per year according to Google Scholar. The right matrix indicates which KBs are accessible through each cancer variant interpretation tool.

Similar articles

Cited by

References

    1. Ortiz MV, Kobos R, Walsh M, et al. Integrating genomics into clinical pediatric oncology using the molecular tumor board at the Memorial Sloan Kettering Cancer Center. Pediatr Blood Cancer 2016; 63(8): 1368–74. - PMC - PubMed
    1. Horak P, Klink B, Heining C, et al. Precision oncology based on omics data: the NCT Heidelberg experience. Int J Cancer 2017. - PubMed
    1. Freedman AN, Klabunde CN, Wiant K, et al. Use of next-generation sequencing tests to guide cancer treatment: results from a nationally representative survey of oncologists in the United States. JCO Precis Oncol 2018; 2:1–13. - PMC - PubMed
    1. Knepper TC, Bell GC, Hicks JK, et al. Key lessons learned from Moffitt’s molecular tumor board: the clinical genomics action committee experience. Oncologist 2017. - PMC - PubMed
    1. Singer F, Irmisch A, Toussaint NC, et al. SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics. BMC Med Inform Decis Mak 2018. - PMC - PubMed

Publication types